ViaLongeVita

Internal Medicine

This article was automatically translated into your selected language.(mymemory)

Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trialVIP

Nature Medicine, Published online: 30 August 2026; doi:10.1038/s41591-026-04670-6 As presented at the 2026 ESC Congress, in a secondary analysis of the CARDIOTTRansform trial testing the transthyretin-targeting antisense oligonucleotide eplontersen in patients with transthyretin amyloid cardiomyopathy, a beneficial eff

MedScopeGlobal Editorial

2026년 8월 31일

이 콘텐츠는 의학적 진단이나 치료 권고가 아닙니다. 항상 의사와 상담하세요.

Illustration for "Eplontersen with and without background transthyretin stabilizers in transthyretin amyloid cardiomyopathy: secondary analysis of a phase 3, randomized controlled trial" — longevity and healthy aging, diverse group of adults

Enjoying this article? Support the editorial team with a tip

Nature Medicine, Published online: 30 August 2026; doi:10.1038/s41591-026-04670-6 As presented at the 2026 ESC Congress, in a secondary analysis of the CARDIOTTRansform trial testing the transthyretin-targeting antisense oligonucleotide eplontersen in patients with transthyretin amyloid cardiomyopathy, a beneficial eff

Exkluzivně pro předplatitele

Pokračujte ve čtení s MedScope Premium

VIP články obsahují klinické dopady, klíčové body a ověřené zdroje — navržené pro studenty a lékaře.

14 dní zkušební verze zdarma — vyzkoušejte bez rizika

Již máte účet? Přihlásit se · Srovnání tarifů

Support the author (MedScopeGlobal Editorial) · Tip

Optional micro-contribution — like a tip. Funds ViaLongeVita editorial.

A tip is not a VIP subscription and does not unlock paid content — it is optional support for the desk.

Contribution

Donate

A micro-donation helps us keep publishing quality content.

Recommended content

Articles

Prepared by the MedScopeGlobal.com editorial team — educational health content for the public. Always consult a physician for personal medical decisions.